...ity, along with colleagues from the California Ins..., Princeton University and other institutions, hav...iously unknown species of microorganism that lived...s, some 55 million years ago. Their results were p...al Academy of Sciences . , The research might hel...
...icials can reduce electricity use in the state sig... Greenhouse Gas Initiative (RGGI) cap-and-trade au...tudy from a University of Maryland-led research te...as well. , Investments might range from direct su...nergy-efficient appliances to technical assistance...
..., 2008) The Marine Mammal Center is seeing a larg...lions this year and is leading a study to determin.... Every four to five years, the Center sees a sur... of this bacterial infection that affects the kidn...esearch will focus on the factors contributing to ...
Other Biology News:Earlier global warming produced a whole new form of life 2Greenhouse gas auction revenues can help cut Md. electric use significantly, says study 2Greenhouse gas auction revenues can help cut Md. electric use significantly, says study 3Greenhouse gas auction revenues can help cut Md. electric use significantly, says study 4Greenhouse gas auction revenues can help cut Md. electric use significantly, says study 5The Marine Mammal Center begins new leptospirosis study in California 2(Date:12/3/2009)TUSTIN, Calif., Dec. 3 Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM ) today announced that it will release its financial results for the second quarter of fiscal year 2010 on December 10, 2009 at 7
(Date:12/2/2009)COLUMBIA, Md., Dec. 2 Martek Biosciences Corporation (Nasdaq: MATK ) announced today that it intends to release the results of its fourth quarter and fiscal year 2009 on December 16, 2009, at approx
(Date:12/2/2009)NEW YORK, Dec. 2 Reportlinker.com announces that a new market research report is available in its catalogue: ,, Drug Discovery Technologies - A Global Update of Market Trends & Opportunities ,,
(Date:12/2/2009)CALGARY, Dec. 2 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. ("Oncolytics" or the "Company") (TSX:ONC; NASDAQ: ONCY ) announced today that in connection with its previously announced unit offering
Breaking Biology Technology:Peregrine Pharmaceuticals to Report Second Quarter FY 2010 Financial Results 2Martek to Announce Fourth Quarter and Fiscal Year 2009 Results 2Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 2Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 3Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 4Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 5Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 6Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 7Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 8Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 9Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 2Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 3Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 4...., March 13 Covance Inc. (NYSE: CVD ) announced...ogy footprint in Europe with the acquisition of Sw...mpany based in Basel, Switzerland. , , "Our clien...cology studies that can help them make decisions f... executive officer. "This acquisition significantl...
... Some of the world,s most respected ener...urity questions during a daylong gathering in Hous...er Houston Partnership once again takes center sta...ting "America,s Energy Future: Assessing Our ... Houston (PRWEB) March 13, 2009 -- Preside...
...Investor Conference Call on Friday, March 13, 2009...pharmaceuticals, Inc. (Nasdaq: KERX ), a biophar...elopment and commercialization of medically import...nt of life-threatening diseases, including renal d... its results for the fourth quarter and year ended...
Other Biology Technology:Covance Increases Early Clinical Footprint in Europe with Acquisition of Swiss-Based Early Clinical Development Site 2Greater Houston Partnership to Lead Energy Security Discussion 2Keryx Biopharmaceuticals, Inc. Announces Fourth Quarter and Year-End 2008 Financial Results 2Keryx Biopharmaceuticals, Inc. Announces Fourth Quarter and Year-End 2008 Financial Results 3Keryx Biopharmaceuticals, Inc. Announces Fourth Quarter and Year-End 2008 Financial Results 4Keryx Biopharmaceuticals, Inc. Announces Fourth Quarter and Year-End 2008 Financial Results 5Keryx Biopharmaceuticals, Inc. Announces Fourth Quarter and Year-End 2008 Financial Results 6...Orbit LS Low Speed Shaker ,Product Information...ity, general purpose shaker with economical analog...e line, the Orbit LS features a streamlined, compa...ic controls are utilized for setting speed and tim...
Benchtop Laminar Flow Hood (Environmental Control Module) from Terra Universal, Inc.
...GyroTwister GX-1000 3-D Shaker , ,Product Informa...he GyroTwister GX-1000 is extremely efficient, yet...ng as well as staining gels, hybridization and oth...ustable across a broad range. A nonslip rubber mat...
...ActiveSight, the leading provider of X-ray crystal... offers fragment-based screening services to its p...based screening involves the binding of drug-like ...ein drug targets, allowing scientists to develop n...
Biology Products: